Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Ocuphire Pharma Inc (OCUP)
Ocuphire Pharma Inc (OCUP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Reata (RETA) Q1 Earnings Miss, Stock Dips on Pipeline Updates

Reata (RETA) incurs wider-than-expected loss in the first quarter. The company discontinues the development of bardoxolone methyl for diabetic kidney disease.

RETA : 172.36 (+0.02%)
RCUS : 19.10 (-0.16%)
ALLO : 4.94 (+0.61%)
OCUP : 2.53 (-0.20%)
TEVA Q1 Earnings Miss Estimates, Sales Beat, Stock Declines

TEVA reports mixed Q1 results, missing earnings estimates but beating the same for revenues. Stock falls.

TEVA : 13.50 (+2.66%)
RCUS : 19.10 (-0.16%)
ALLO : 4.94 (+0.61%)
OCUP : 2.53 (-0.20%)
Amicus (FOLD) Q1 Earnings Miss, Galafold Sales Grow

Amicus (FOLD) incurs wider-than-expected loss in the first quarter. Revenues, however, beat estimates. The company reiterates its 2023 guidance.

FOLD : 13.29 (+3.67%)
RCUS : 19.10 (-0.16%)
ALLO : 4.94 (+0.61%)
OCUP : 2.53 (-0.20%)
Halozyme (HALO) Q1 Earnings Disappoint, Revenues Rise Y/Y

Halozyme (HALO) first-quarter earnings and revenues miss estimates. The company reiterates its guidance for 2023.

RHHBY : 33.0800 (+1.07%)
JNJ : 162.12 (+0.46%)
HALO : 41.11 (+3.27%)
OCUP : 2.53 (-0.20%)
Emergent (EBS) Q1 Earnings Miss Estimates, Revenues Beat

Emergent (EBS) reports wider-than-expected first-quarter loss. The company updates its 2023 guidance for selected categories.

AZN : 64.60 (+0.69%)
JNJ : 162.12 (+0.46%)
EBS : 3.39 (+4.95%)
OCUP : 2.53 (-0.20%)
Axsome (AXSM) Q1 Earnings Beat Estimates, Auvelity Volume Rises

Axsome (AXSM) incurs a narrower-than-expected loss in 1Q23. Its revenues beat estimates and stock gains.

JAZZ : 118.85 (-0.04%)
AXSM : 82.42 (+1.28%)
ALLO : 4.94 (+0.61%)
OCUP : 2.53 (-0.20%)
CRISPR Therapeutics (CRSP) Q1 Earnings and Revenues Beat

CRISPR Therapeutics (CRSP) provides updates for its gene therapy candidates.

VRTX : 432.76 (+2.86%)
CRSP : 83.75 (-0.56%)
ALLO : 4.94 (+0.61%)
OCUP : 2.53 (-0.20%)
Intra-Cellular (ITCI) Q1 Earnings Top, Caplyta Volume Rises

Intra-Cellular (ITCI) first-quarter earnings and revenues beat estimates. The company reiterates its previously issued guidance for 2023.

ITCI : 71.49 (+2.83%)
RCUS : 19.10 (-0.16%)
ALLO : 4.94 (+0.61%)
OCUP : 2.53 (-0.20%)
Recent Price Trend in Ocuphire Pharma, Inc. (OCUP) is Your Friend, Here's Why

If you are looking for stocks that are well positioned to maintain their recent uptrend, Ocuphire Pharma, Inc. (OCUP) could be a great choice. It is one of the several stocks that passed through our "Recent...

OCUP : 2.53 (-0.20%)
Puma Biotech (PBYI) Q1 Earnings Beat, Nerlynx Sales Rise Y/Y

Puma Biotechnology (PBYI) earnings and sales beat estimates in Q1. Stock rises in after-hours.

PBYI : 5.89 (-5.31%)
RCUS : 19.10 (-0.16%)
ALLO : 4.94 (+0.61%)
OCUP : 2.53 (-0.20%)

Barchart Exclusives

Recession Warning: 5 Stocks to Avoid After Jamie Dimon's Cautious Economic Outlook
Many investors are pricing in a "soft landing," but Dimon says companies in industries like commercial real estate and banking could still remain vulnerable to macro headwinds, such as interest rates, inflation, and unemployment rates. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar